The application of mRNA-based gene transfer in mesenchymal stem cell-mediated cytotoxicity of glioma cells

Xing Rong Guo; Zhuo Shun Yang; Xiang Jun Tang; Dan Dan Zou; Hui Gui; Xiao Li Wang; Shi Nan Ma; Ya Hong Yuan; Juan Fang; Bin Wang; Li Zhang; Xu Yong Sun; Garth L. Warnock; Long Jun Dai; Han Jun Tu

doi:10.18632/oncotarget.10835

The application of mRNA-based gene transfer in mesenchymal stem cell-mediated cytotoxicity of glioma cells

Xing Rong Guo, Zhuo Shun Yang, Xiang Jun Tang, Dan Dan Zou, Hui Gui, Xiao Li Wang, Shi Nan Ma, Ya Hong Yuan, Juan Fang, Bin Wang, Li Zhang, Xu Yong Sun, Garth L. Warnock, Long Jun Dai, Han Jun Tu

Research output: Contribution to journal › Article › peer-review

18 Scopus citations

Abstract

Since the tumor-oriented homing capacity of mesenchymal stem cells (MSCs) was discovered, MSCs have attracted great interest in the research field of cancer therapy mainly focused on their use as carries for anticancer agents. Differing from DNA-based vectors, the use of mRNA-based antituor gene delivery benefits from readily transfection and mutagenesis-free. However, it is essential to verify if mRNA transfection interferes with MSCs' tropism and their antitumor properties. TRAIL- and PTEN-mRNAs were synthesized and studied in an in vitro model of MSC-mediated indirect co-culture with DBTRG human glioma cells. The expression of TRAIL and PTEN in transfected MSCs was verified by immunoblotting analysis, and the migration ability of MSCs after anticancer gene transfection was demonstrated using transwell co-cultures. The viability of DBTRG cells was determined with bioluminescence, live/dead staining and real time cell analyzer. An in vivo model of DBTRG cell-derived xenografted tumors was used to verify the antitumor effects of TRAIL- and PTEN-engineered MSCs. With regard to the effect of mRNA transfection on MSCs' migration toward glioma cells, an enhanced migration rate was observed with MSCs transfected with all tested mRNAs compared to non-transfected MSCs (p<0.05). TRAIL- and PTEN-mRNA-induced cytotoxicity of DBTRG glioma cells was proportionally correlated with the ratio of conditioned medium from transfected MSCs. A synergistic action of TRAIL and PTEN was demonstrated in the current co-culture model. The immunoblotting analysis revealed the apoptotic nature of the cells death in the present study. The growth of the xenografted tumors was significantly inhibited by the application of MSCPTEN or MSCTRAIL/PTEN on day 14 and MSCTRAIL on day 28 (p<0.05). The results suggested that anticancer gene-bearing mRNAs synthesized in vitro are capable of being applied for MSC-mediated anticancer modality. This study provides an experimental base for further clinical anticancer studies using synthesized mRNAs.

Original language	English
Pages (from-to)	55529-55542
Number of pages	14
Journal	Oncotarget
Volume	7
Issue number	34
DOIs	https://doi.org/10.18632/oncotarget.10835
State	Published - 23 Aug 2016
Externally published	Yes

Keywords

PTEN
TRAIL
cancer therapy
glioblastoma
mesenchymal stem cells

Access to Document

10.18632/oncotarget.10835

Cite this

@article{41621608b09e46ba851c98ebcac6d702,

title = "The application of mRNA-based gene transfer in mesenchymal stem cell-mediated cytotoxicity of glioma cells",

abstract = "Since the tumor-oriented homing capacity of mesenchymal stem cells (MSCs) was discovered, MSCs have attracted great interest in the research field of cancer therapy mainly focused on their use as carries for anticancer agents. Differing from DNA-based vectors, the use of mRNA-based antituor gene delivery benefits from readily transfection and mutagenesis-free. However, it is essential to verify if mRNA transfection interferes with MSCs' tropism and their antitumor properties. TRAIL- and PTEN-mRNAs were synthesized and studied in an in vitro model of MSC-mediated indirect co-culture with DBTRG human glioma cells. The expression of TRAIL and PTEN in transfected MSCs was verified by immunoblotting analysis, and the migration ability of MSCs after anticancer gene transfection was demonstrated using transwell co-cultures. The viability of DBTRG cells was determined with bioluminescence, live/dead staining and real time cell analyzer. An in vivo model of DBTRG cell-derived xenografted tumors was used to verify the antitumor effects of TRAIL- and PTEN-engineered MSCs. With regard to the effect of mRNA transfection on MSCs' migration toward glioma cells, an enhanced migration rate was observed with MSCs transfected with all tested mRNAs compared to non-transfected MSCs (p<0.05). TRAIL- and PTEN-mRNA-induced cytotoxicity of DBTRG glioma cells was proportionally correlated with the ratio of conditioned medium from transfected MSCs. A synergistic action of TRAIL and PTEN was demonstrated in the current co-culture model. The immunoblotting analysis revealed the apoptotic nature of the cells death in the present study. The growth of the xenografted tumors was significantly inhibited by the application of MSCPTEN or MSCTRAIL/PTEN on day 14 and MSCTRAIL on day 28 (p<0.05). The results suggested that anticancer gene-bearing mRNAs synthesized in vitro are capable of being applied for MSC-mediated anticancer modality. This study provides an experimental base for further clinical anticancer studies using synthesized mRNAs.",

keywords = "PTEN, TRAIL, cancer therapy, glioblastoma, mesenchymal stem cells",

author = "Guo, {Xing Rong} and Yang, {Zhuo Shun} and Tang, {Xiang Jun} and Zou, {Dan Dan} and Hui Gui and Wang, {Xiao Li} and Ma, {Shi Nan} and Yuan, {Ya Hong} and Juan Fang and Bin Wang and Li Zhang and Sun, {Xu Yong} and Warnock, {Garth L.} and Dai, {Long Jun} and Tu, {Han Jun}",

year = "2016",

month = aug,

day = "23",

doi = "10.18632/oncotarget.10835",

language = "English",

volume = "7",

pages = "55529--55542",

journal = "Oncotarget",

issn = "1949-2553",

publisher = "Impact Journals LLC",

number = "34",

}

TY - JOUR

T1 - The application of mRNA-based gene transfer in mesenchymal stem cell-mediated cytotoxicity of glioma cells

AU - Guo, Xing Rong

AU - Yang, Zhuo Shun

AU - Tang, Xiang Jun

AU - Zou, Dan Dan

AU - Gui, Hui

AU - Wang, Xiao Li

AU - Ma, Shi Nan

AU - Yuan, Ya Hong

AU - Fang, Juan

AU - Wang, Bin

AU - Zhang, Li

AU - Sun, Xu Yong

AU - Warnock, Garth L.

AU - Dai, Long Jun

AU - Tu, Han Jun

PY - 2016/8/23

Y1 - 2016/8/23

N2 - Since the tumor-oriented homing capacity of mesenchymal stem cells (MSCs) was discovered, MSCs have attracted great interest in the research field of cancer therapy mainly focused on their use as carries for anticancer agents. Differing from DNA-based vectors, the use of mRNA-based antituor gene delivery benefits from readily transfection and mutagenesis-free. However, it is essential to verify if mRNA transfection interferes with MSCs' tropism and their antitumor properties. TRAIL- and PTEN-mRNAs were synthesized and studied in an in vitro model of MSC-mediated indirect co-culture with DBTRG human glioma cells. The expression of TRAIL and PTEN in transfected MSCs was verified by immunoblotting analysis, and the migration ability of MSCs after anticancer gene transfection was demonstrated using transwell co-cultures. The viability of DBTRG cells was determined with bioluminescence, live/dead staining and real time cell analyzer. An in vivo model of DBTRG cell-derived xenografted tumors was used to verify the antitumor effects of TRAIL- and PTEN-engineered MSCs. With regard to the effect of mRNA transfection on MSCs' migration toward glioma cells, an enhanced migration rate was observed with MSCs transfected with all tested mRNAs compared to non-transfected MSCs (p<0.05). TRAIL- and PTEN-mRNA-induced cytotoxicity of DBTRG glioma cells was proportionally correlated with the ratio of conditioned medium from transfected MSCs. A synergistic action of TRAIL and PTEN was demonstrated in the current co-culture model. The immunoblotting analysis revealed the apoptotic nature of the cells death in the present study. The growth of the xenografted tumors was significantly inhibited by the application of MSCPTEN or MSCTRAIL/PTEN on day 14 and MSCTRAIL on day 28 (p<0.05). The results suggested that anticancer gene-bearing mRNAs synthesized in vitro are capable of being applied for MSC-mediated anticancer modality. This study provides an experimental base for further clinical anticancer studies using synthesized mRNAs.

AB - Since the tumor-oriented homing capacity of mesenchymal stem cells (MSCs) was discovered, MSCs have attracted great interest in the research field of cancer therapy mainly focused on their use as carries for anticancer agents. Differing from DNA-based vectors, the use of mRNA-based antituor gene delivery benefits from readily transfection and mutagenesis-free. However, it is essential to verify if mRNA transfection interferes with MSCs' tropism and their antitumor properties. TRAIL- and PTEN-mRNAs were synthesized and studied in an in vitro model of MSC-mediated indirect co-culture with DBTRG human glioma cells. The expression of TRAIL and PTEN in transfected MSCs was verified by immunoblotting analysis, and the migration ability of MSCs after anticancer gene transfection was demonstrated using transwell co-cultures. The viability of DBTRG cells was determined with bioluminescence, live/dead staining and real time cell analyzer. An in vivo model of DBTRG cell-derived xenografted tumors was used to verify the antitumor effects of TRAIL- and PTEN-engineered MSCs. With regard to the effect of mRNA transfection on MSCs' migration toward glioma cells, an enhanced migration rate was observed with MSCs transfected with all tested mRNAs compared to non-transfected MSCs (p<0.05). TRAIL- and PTEN-mRNA-induced cytotoxicity of DBTRG glioma cells was proportionally correlated with the ratio of conditioned medium from transfected MSCs. A synergistic action of TRAIL and PTEN was demonstrated in the current co-culture model. The immunoblotting analysis revealed the apoptotic nature of the cells death in the present study. The growth of the xenografted tumors was significantly inhibited by the application of MSCPTEN or MSCTRAIL/PTEN on day 14 and MSCTRAIL on day 28 (p<0.05). The results suggested that anticancer gene-bearing mRNAs synthesized in vitro are capable of being applied for MSC-mediated anticancer modality. This study provides an experimental base for further clinical anticancer studies using synthesized mRNAs.

KW - PTEN

KW - TRAIL

KW - cancer therapy

KW - glioblastoma

KW - mesenchymal stem cells

UR - http://www.scopus.com/inward/record.url?scp=85041771661&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.10835

DO - 10.18632/oncotarget.10835

M3 - Article

C2 - 27487125

AN - SCOPUS:85041771661

SN - 1949-2553

VL - 7

SP - 55529

EP - 55542

JO - Oncotarget

JF - Oncotarget

IS - 34

ER -

The application of mRNA-based gene transfer in mesenchymal stem cell-mediated cytotoxicity of glioma cells

Abstract

Keywords

Access to Document

Fingerprint

Cite this